Skip to Main Content

Paper Details

Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation.
Int J Biol Sci
2
2023
Breast Cancer, CD3, CD4, CD4 T cell subset, CD4 Th1 and Th17 cells, CD69, EGFR, RNase1, RNase1-expressing tumor cells, Ribonuclease 1, T, T cell, Th1, anti-, breast cancer, breast cancer cells, cancer, granulocytic myeloid-derived suppressor cells, human, human ribonuclease 1, mouse, natural killer cells, patients, tumor, tumors
Author NameAffiliation
Zhou JiangThe University of Texas MD Anderson Cancer Center
Gabriel N HortobagyiThe University of Texas MD Anderson Cancer Center
Mien-Chie HungGraduate Institute of Biomedical Sciences, Institute of Biochemistry and Molecular Biology, Research Center for Cancer Biology, and Center for Molecular Medicine, China Medical University
Mien-Chie HungThe University of Texas MD Anderson Cancer Center
Mien-Chie HungAsia University
  • 1 - 5

Datasets

Release 1.2